Home›Companies›Biotech & Pharma›Blue Marlin Therapeutics

Blue Marlin Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing Oct 21, 2025·Suggest an edit

About Blue Marlin Therapeutics

Blue Marlin Therapeutics is a private company based in Charlottesville, Virginia, incorporated in 2025 in Delaware. It has reported $100,000 raised in one offering on Form D since October 2025. Its chief executive is Paul Manning.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 6, 2025Oct 21, 2025$100,000target not set2$50,000EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Blue Marlin Therapeutics's Form D filed Oct 21, 2025.

PM
Paul Manning
Chief Executive Officer
SS
Sean Stalfort
President and Secretary

Sources

  1. SECBlue Marlin Therapeutics, Inc. filing history